

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of interleukin-12 production (GO:0032695) | 5.34141999 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.66002670 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.66002670 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.55777125 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.55777125 |
| 6 | macrophage activation involved in immune response (GO:0002281) | 4.39043397 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 4.21416364 |
| 8 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.14396485 |
| 9 | negative regulation of cell killing (GO:0031342) | 4.05029015 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.05029015 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.03888229 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.03164122 |
| 13 | complement activation, alternative pathway (GO:0006957) | 3.97186174 |
| 14 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.95530009 |
| 15 | NIK/NF-kappaB signaling (GO:0038061) | 3.84840090 |
| 16 | indole-containing compound catabolic process (GO:0042436) | 3.82205213 |
| 17 | indolalkylamine catabolic process (GO:0046218) | 3.82205213 |
| 18 | tryptophan catabolic process (GO:0006569) | 3.82205213 |
| 19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.79610126 |
| 20 | protein carboxylation (GO:0018214) | 3.79610126 |
| 21 | glyoxylate metabolic process (GO:0046487) | 3.72860671 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.70326188 |
| 23 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.68750478 |
| 24 | tryptophan metabolic process (GO:0006568) | 3.66732222 |
| 25 | aldehyde catabolic process (GO:0046185) | 3.66292863 |
| 26 | cellular response to type I interferon (GO:0071357) | 3.65221405 |
| 27 | type I interferon signaling pathway (GO:0060337) | 3.65221405 |
| 28 | kynurenine metabolic process (GO:0070189) | 3.65073815 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.64232755 |
| 30 | plasma lipoprotein particle clearance (GO:0034381) | 3.61814570 |
| 31 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.60420777 |
| 32 | response to type I interferon (GO:0034340) | 3.60234264 |
| 33 | urea metabolic process (GO:0019627) | 3.59938269 |
| 34 | urea cycle (GO:0000050) | 3.59938269 |
| 35 | bile acid biosynthetic process (GO:0006699) | 3.58775114 |
| 36 | sulfur amino acid catabolic process (GO:0000098) | 3.56635110 |
| 37 | T-helper 1 type immune response (GO:0042088) | 3.55830395 |
| 38 | cysteine metabolic process (GO:0006534) | 3.53924036 |
| 39 | granulocyte activation (GO:0036230) | 3.53468182 |
| 40 | alpha-linolenic acid metabolic process (GO:0036109) | 3.46104898 |
| 41 | myeloid dendritic cell differentiation (GO:0043011) | 3.45649481 |
| 42 | germinal center formation (GO:0002467) | 3.45286744 |
| 43 | detection of molecule of bacterial origin (GO:0032490) | 3.43698042 |
| 44 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.43205443 |
| 45 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.41956378 |
| 46 | regulation of podosome assembly (GO:0071801) | 3.41655141 |
| 47 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.40517336 |
| 48 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.40209238 |
| 49 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.40209238 |
| 50 | detection of other organism (GO:0098543) | 3.38228154 |
| 51 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.37906588 |
| 52 | regulation of protein activation cascade (GO:2000257) | 3.37164278 |
| 53 | nitrogen cycle metabolic process (GO:0071941) | 3.36027288 |
| 54 | defense response to protozoan (GO:0042832) | 3.35237186 |
| 55 | regulation of mononuclear cell migration (GO:0071675) | 3.33947757 |
| 56 | high-density lipoprotein particle remodeling (GO:0034375) | 3.33184353 |
| 57 | negative regulation of fibrinolysis (GO:0051918) | 3.29447896 |
| 58 | response to protozoan (GO:0001562) | 3.26244393 |
| 59 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.25001108 |
| 60 | neutrophil activation involved in immune response (GO:0002283) | 3.22302559 |
| 61 | regulation of complement activation (GO:0030449) | 3.21061542 |
| 62 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.21020033 |
| 63 | neutrophil activation (GO:0042119) | 3.20390434 |
| 64 | response to muramyl dipeptide (GO:0032495) | 3.20358787 |
| 65 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.18298715 |
| 66 | phospholipid efflux (GO:0033700) | 3.17763142 |
| 67 | detection of bacterium (GO:0016045) | 3.17211995 |
| 68 | regulation of cholesterol esterification (GO:0010872) | 3.16865894 |
| 69 | response to peptidoglycan (GO:0032494) | 3.15879997 |
| 70 | positive regulation of type 2 immune response (GO:0002830) | 3.14575249 |
| 71 | regulation of chemokine biosynthetic process (GO:0045073) | 3.13741630 |
| 72 | regulation of chronic inflammatory response (GO:0002676) | 3.12282252 |
| 73 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.12165440 |
| 74 | detection of external biotic stimulus (GO:0098581) | 3.11977416 |
| 75 | regulation of triglyceride catabolic process (GO:0010896) | 3.10898052 |
| 76 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.10807492 |
| 77 | regulation of vitamin metabolic process (GO:0030656) | 3.10574206 |
| 78 | myeloid cell activation involved in immune response (GO:0002275) | 3.09601329 |
| 79 | regulation of T cell tolerance induction (GO:0002664) | 3.08637358 |
| 80 | reverse cholesterol transport (GO:0043691) | 3.08073454 |
| 81 | myeloid dendritic cell activation (GO:0001773) | 3.07791710 |
| 82 | regulation of fibrinolysis (GO:0051917) | 3.07393092 |
| 83 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.06671584 |
| 84 | regulation of interleukin-12 production (GO:0032655) | 3.06016895 |
| 85 | macrophage activation (GO:0042116) | 3.05854307 |
| 86 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.04756857 |
| 87 | modulation by symbiont of host immune response (GO:0052553) | 3.04756857 |
| 88 | positive regulation by symbiont of host defense response (GO:0052509) | 3.04756857 |
| 89 | modulation by symbiont of host defense response (GO:0052031) | 3.04756857 |
| 90 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.04756857 |
| 91 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.04756857 |
| 92 | immunoglobulin mediated immune response (GO:0016064) | 3.04321491 |
| 93 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.03479904 |
| 94 | plasma lipoprotein particle remodeling (GO:0034369) | 3.02275303 |
| 95 | protein-lipid complex remodeling (GO:0034368) | 3.02275303 |
| 96 | macromolecular complex remodeling (GO:0034367) | 3.02275303 |
| 97 | aromatic amino acid family metabolic process (GO:0009072) | 3.01652805 |
| 98 | lysine catabolic process (GO:0006554) | 3.01562281 |
| 99 | lysine metabolic process (GO:0006553) | 3.01562281 |
| 100 | cofactor catabolic process (GO:0051187) | 3.01496384 |
| 101 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.99305244 |
| 102 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.99305244 |
| 103 | regulation of antigen processing and presentation (GO:0002577) | 2.99260247 |
| 104 | regulation of mast cell degranulation (GO:0043304) | 2.99237080 |
| 105 | positive regulation of antigen processing and presentation (GO:0002579) | 2.99038964 |
| 106 | amino-acid betaine metabolic process (GO:0006577) | 2.98612057 |
| 107 | B cell mediated immunity (GO:0019724) | 2.97312125 |
| 108 | bile acid metabolic process (GO:0008206) | 2.97234149 |
| 109 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.96442652 |
| 110 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.95985533 |
| 111 | positive regulation of interferon-alpha production (GO:0032727) | 2.95729957 |
| 112 | positive regulation of heat generation (GO:0031652) | 2.95547466 |
| 113 | respiratory burst (GO:0045730) | 2.94023040 |
| 114 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.93907605 |
| 115 | regulation of gamma-delta T cell activation (GO:0046643) | 2.93678549 |
| 116 | glycosphingolipid catabolic process (GO:0046479) | 2.92321892 |
| 117 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.91441504 |
| 118 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.91070916 |
| 119 | acute-phase response (GO:0006953) | 2.90815522 |
| 120 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.90170273 |
| 121 | detection of biotic stimulus (GO:0009595) | 2.86141652 |
| 122 | urate metabolic process (GO:0046415) | 2.85990190 |
| 123 | low-density lipoprotein particle clearance (GO:0034383) | 2.85858487 |
| 124 | leukocyte aggregation (GO:0070486) | 2.85221150 |
| 125 | cellular extravasation (GO:0045123) | 2.83602033 |
| 126 | cellular response to lipopolysaccharide (GO:0071222) | 2.81591061 |
| 127 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.80435448 |
| 128 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.80435448 |
| 129 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.80268082 |
| 130 | NAD biosynthetic process (GO:0009435) | 2.79942101 |
| 131 | regulation of interferon-alpha production (GO:0032647) | 2.79629680 |
| 132 | regulation of fever generation (GO:0031620) | 2.79566279 |
| 133 | cellular response to molecule of bacterial origin (GO:0071219) | 2.78749281 |
| 134 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.78577321 |
| 135 | tyrosine metabolic process (GO:0006570) | 2.78138632 |
| 136 | regulation of cholesterol storage (GO:0010885) | 2.77669371 |
| 137 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.77230104 |
| 138 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.77230104 |
| 139 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.76944596 |
| 140 | response to host immune response (GO:0052572) | 2.76944596 |
| 141 | lymphocyte chemotaxis (GO:0048247) | 2.76926548 |
| 142 | low-density lipoprotein particle remodeling (GO:0034374) | 2.76866551 |
| 143 | triglyceride homeostasis (GO:0070328) | 2.76837634 |
| 144 | acylglycerol homeostasis (GO:0055090) | 2.76837634 |
| 145 | regulation of tolerance induction (GO:0002643) | 2.76498843 |
| 146 | complement activation (GO:0006956) | 2.76035510 |
| 147 | response to interferon-beta (GO:0035456) | 2.75884842 |
| 148 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.75767459 |
| 149 | fibrinolysis (GO:0042730) | 2.75136524 |
| 150 | regulation of type 2 immune response (GO:0002828) | 2.74336174 |
| 151 | dendritic cell differentiation (GO:0097028) | 2.74308043 |
| 152 | cellular response to interferon-gamma (GO:0071346) | 2.74276210 |
| 153 | positive regulation of interleukin-10 production (GO:0032733) | 2.74273964 |
| 154 | negative regulation of cholesterol transport (GO:0032375) | 2.72390591 |
| 155 | negative regulation of sterol transport (GO:0032372) | 2.72390591 |
| 156 | plasma lipoprotein particle assembly (GO:0034377) | 2.72100907 |
| 157 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.71909700 |
| 158 | protein activation cascade (GO:0072376) | 2.71613202 |
| 159 | monocyte chemotaxis (GO:0002548) | 2.70977806 |
| 160 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.70970944 |
| 161 | homocysteine metabolic process (GO:0050667) | 2.70941998 |
| 162 | cholesterol efflux (GO:0033344) | 2.70938858 |
| 163 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.70339868 |
| 164 | cellular biogenic amine catabolic process (GO:0042402) | 2.69809294 |
| 165 | amine catabolic process (GO:0009310) | 2.69809294 |
| 166 | serine family amino acid catabolic process (GO:0009071) | 2.69193546 |
| 167 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.67907445 |
| 168 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.67801174 |
| 169 | valine metabolic process (GO:0006573) | 2.67744174 |
| 170 | microglial cell activation (GO:0001774) | 2.67722005 |
| 171 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.67330329 |
| 172 | complement activation, classical pathway (GO:0006958) | 2.65994967 |
| 173 | indolalkylamine metabolic process (GO:0006586) | 2.65692226 |
| 174 | oligosaccharide catabolic process (GO:0009313) | 2.65687881 |
| 175 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.65266816 |
| 176 | reactive oxygen species biosynthetic process (GO:1903409) | 2.65079985 |
| 177 | response to interferon-gamma (GO:0034341) | 2.64760819 |
| 178 | negative regulation of T cell mediated immunity (GO:0002710) | 2.63379495 |
| 179 | ethanol oxidation (GO:0006069) | 2.62218139 |
| 180 | arginine metabolic process (GO:0006525) | 2.58418963 |
| 181 | blood coagulation, intrinsic pathway (GO:0007597) | 2.57728785 |
| 182 | alpha-amino acid catabolic process (GO:1901606) | 2.57127641 |
| 183 | opsonization (GO:0008228) | 2.56733076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.55453937 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.69024236 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.64930856 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.54553740 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.08187453 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.94400931 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.93357554 |
| 8 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.43884862 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.31723674 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.15814490 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.92676394 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.79617400 |
| 13 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.62316975 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.59627392 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.57119395 |
| 16 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.55441664 |
| 17 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.50664707 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.37844654 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.36319043 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.31547483 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.28338354 |
| 22 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.13251023 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12289869 |
| 24 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.03539783 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.00452084 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.91812221 |
| 27 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.76895313 |
| 28 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.74869342 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.73606349 |
| 30 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.71092942 |
| 31 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69851685 |
| 32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.66484507 |
| 33 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.61373264 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.59332303 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58577538 |
| 36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58353834 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.52846132 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.52844268 |
| 39 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51342916 |
| 40 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.49380319 |
| 41 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45114817 |
| 42 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.44963364 |
| 43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.41226435 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39441832 |
| 45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36385734 |
| 46 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35514727 |
| 47 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.35343702 |
| 48 | MAF_26560356_Chip-Seq_TH2_Human | 1.35034431 |
| 49 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33253527 |
| 50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.32936120 |
| 51 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.31837049 |
| 52 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.30057822 |
| 53 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.29326859 |
| 54 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.27325702 |
| 55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25031090 |
| 56 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.22573259 |
| 57 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19549968 |
| 58 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19022751 |
| 59 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18019923 |
| 60 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16903899 |
| 61 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.16859203 |
| 62 | MAF_26560356_Chip-Seq_TH1_Human | 1.14422646 |
| 63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14152219 |
| 64 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.13543793 |
| 65 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11455727 |
| 66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10262918 |
| 67 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09375230 |
| 68 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.08941576 |
| 69 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06885752 |
| 70 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06566486 |
| 71 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06413784 |
| 72 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.05838858 |
| 73 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04803899 |
| 74 | MYB_26560356_Chip-Seq_TH2_Human | 1.04586644 |
| 75 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04397008 |
| 76 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.04191217 |
| 77 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04035105 |
| 78 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03408075 |
| 79 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.03093985 |
| 80 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.02665657 |
| 81 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02155934 |
| 82 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01522654 |
| 83 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.99785626 |
| 84 | SPI1_23127762_ChIP-Seq_K562_Human | 0.99736699 |
| 85 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97840120 |
| 86 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.97195938 |
| 87 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.97154298 |
| 88 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.97117840 |
| 89 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96993239 |
| 90 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.96911775 |
| 91 | MYB_26560356_Chip-Seq_TH1_Human | 0.96397470 |
| 92 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95734121 |
| 93 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.95568333 |
| 94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94661606 |
| 95 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91547562 |
| 96 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.89670358 |
| 97 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.88294364 |
| 98 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.87337719 |
| 99 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.86884034 |
| 100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.86353051 |
| 101 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86336626 |
| 102 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.84147487 |
| 103 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.84035841 |
| 104 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84003604 |
| 105 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82151609 |
| 106 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.80689825 |
| 107 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.80140217 |
| 108 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.79669925 |
| 109 | * MYC_22102868_ChIP-Seq_BL_Human | 0.78519397 |
| 110 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78273998 |
| 111 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.77991911 |
| 112 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.77975563 |
| 113 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.77728695 |
| 114 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.77538090 |
| 115 | GATA3_26560356_Chip-Seq_TH2_Human | 0.77174603 |
| 116 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.77110437 |
| 117 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.76713991 |
| 118 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.76636959 |
| 119 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.76413407 |
| 120 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76264666 |
| 121 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.76021171 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.75179097 |
| 2 | MP0005360_urolithiasis | 4.22032526 |
| 3 | MP0005365_abnormal_bile_salt | 3.53007092 |
| 4 | MP0009840_abnormal_foam_cell | 3.42513403 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.28945961 |
| 6 | MP0003436_decreased_susceptibility_to | 2.83236017 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 2.80828959 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.66723239 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 2.60553048 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.50241512 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.48493116 |
| 12 | MP0009785_altered_susceptibility_to | 2.48140237 |
| 13 | MP0003195_calcinosis | 2.42346156 |
| 14 | MP0003724_increased_susceptibility_to | 2.39878933 |
| 15 | MP0005083_abnormal_biliary_tract | 2.34327259 |
| 16 | MP0003252_abnormal_bile_duct | 2.12524627 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.11053980 |
| 18 | MP0002419_abnormal_innate_immunity | 2.10039221 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.05731576 |
| 20 | MP0005025_abnormal_response_to | 2.00085508 |
| 21 | MP0006082_CNS_inflammation | 1.99294617 |
| 22 | MP0000685_abnormal_immune_system | 1.96436972 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 1.95193941 |
| 24 | MP0003186_abnormal_redox_activity | 1.90217827 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.90041859 |
| 26 | MP0005000_abnormal_immune_tolerance | 1.79223875 |
| 27 | MP0005332_abnormal_amino_acid | 1.77455363 |
| 28 | MP0008469_abnormal_protein_level | 1.70228694 |
| 29 | MP0000609_abnormal_liver_physiology | 1.68735416 |
| 30 | MP0003303_peritoneal_inflammation | 1.66727231 |
| 31 | MP0001790_abnormal_immune_system | 1.64951192 |
| 32 | MP0005387_immune_system_phenotype | 1.64951192 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.59266626 |
| 34 | MP0009764_decreased_sensitivity_to | 1.54604159 |
| 35 | MP0001853_heart_inflammation | 1.50811037 |
| 36 | MP0005451_abnormal_body_composition | 1.49922911 |
| 37 | MP0002452_abnormal_antigen_presenting | 1.49052802 |
| 38 | MP0004510_myositis | 1.48359411 |
| 39 | MP0002723_abnormal_immune_serum | 1.48264222 |
| 40 | MP0001800_abnormal_humoral_immune | 1.47688751 |
| 41 | MP0001666_abnormal_nutrient_absorption | 1.46790299 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.45714458 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.43494464 |
| 44 | MP0008004_abnormal_stomach_pH | 1.43140380 |
| 45 | MP0003656_abnormal_erythrocyte_physiolo | 1.42279670 |
| 46 | MP0005671_abnormal_response_to | 1.41037634 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.39068887 |
| 48 | MP0002118_abnormal_lipid_homeostasis | 1.38543567 |
| 49 | MP0001764_abnormal_homeostasis | 1.36238316 |
| 50 | MP0004019_abnormal_vitamin_homeostasis | 1.34528838 |
| 51 | MP0000604_amyloidosis | 1.33879426 |
| 52 | MP0003453_abnormal_keratinocyte_physiol | 1.32656583 |
| 53 | MP0000343_altered_response_to | 1.32406393 |
| 54 | MP0009643_abnormal_urine_homeostasis | 1.31079069 |
| 55 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.30714515 |
| 56 | MP0009763_increased_sensitivity_to | 1.30570220 |
| 57 | MP0004947_skin_inflammation | 1.25363883 |
| 58 | MP0001819_abnormal_immune_cell | 1.24222445 |
| 59 | MP0002420_abnormal_adaptive_immunity | 1.23093544 |
| 60 | MP0006054_spinal_hemorrhage | 1.22036686 |
| 61 | MP0008260_abnormal_autophagy | 1.19016499 |
| 62 | MP0000598_abnormal_liver_morphology | 1.15666995 |
| 63 | MP0010155_abnormal_intestine_physiology | 1.15221644 |
| 64 | MP0003075_altered_response_to | 1.14962304 |
| 65 | MP0002332_abnormal_exercise_endurance | 1.10874684 |
| 66 | MP0002405_respiratory_system_inflammati | 1.08930372 |
| 67 | MP0009333_abnormal_splenocyte_physiolog | 1.08516392 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 1.07875293 |
| 69 | MP0001545_abnormal_hematopoietic_system | 1.07875293 |
| 70 | MP0003763_abnormal_thymus_physiology | 1.04467094 |
| 71 | MP0003300_gastrointestinal_ulcer | 1.03078784 |
| 72 | MP0005164_abnormal_response_to | 1.02475109 |
| 73 | MP0002254_reproductive_system_inflammat | 1.00646595 |
| 74 | MP0009278_abnormal_bone_marrow | 1.00081050 |
| 75 | MP0002277_abnormal_respiratory_mucosa | 0.99009930 |
| 76 | MP0000689_abnormal_spleen_morphology | 0.96984397 |
| 77 | MP0000716_abnormal_immune_system | 0.95858032 |
| 78 | MP0003011_delayed_dark_adaptation | 0.95603043 |
| 79 | MP0005390_skeleton_phenotype | 0.95374169 |
| 80 | MP0005084_abnormal_gallbladder_morpholo | 0.95352708 |
| 81 | MP0003828_pulmonary_edema | 0.95070223 |
| 82 | MP0003868_abnormal_feces_composition | 0.92931099 |
| 83 | MP0006036_abnormal_mitochondrial_physio | 0.92708018 |
| 84 | MP0010368_abnormal_lymphatic_system | 0.91961282 |
| 85 | MP0005636_abnormal_mineral_homeostasis | 0.89405274 |
| 86 | MP0005310_abnormal_salivary_gland | 0.88985999 |
| 87 | MP0001663_abnormal_digestive_system | 0.88027160 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.87866742 |
| 89 | MP0009642_abnormal_blood_homeostasis | 0.85522910 |
| 90 | MP0000465_gastrointestinal_hemorrhage | 0.85224258 |
| 91 | MP0003183_abnormal_peptide_metabolism | 0.85003824 |
| 92 | MP0004782_abnormal_surfactant_physiolog | 0.84701775 |
| 93 | MP0004883_abnormal_blood_vessel | 0.84671978 |
| 94 | MP0002398_abnormal_bone_marrow | 0.83452614 |
| 95 | MP0000920_abnormal_myelination | 0.83334744 |
| 96 | MP0002429_abnormal_blood_cell | 0.82842551 |
| 97 | MP0003646_muscle_fatigue | 0.82744360 |
| 98 | MP0005408_hypopigmentation | 0.82026083 |
| 99 | MP0001873_stomach_inflammation | 0.80319430 |
| 100 | MP0002998_abnormal_bone_remodeling | 0.80093530 |
| 101 | MP0002136_abnormal_kidney_physiology | 0.79739411 |
| 102 | MP0005166_decreased_susceptibility_to | 0.79192194 |
| 103 | MP0000249_abnormal_blood_vessel | 0.76496132 |
| 104 | MP0000858_altered_metastatic_potential | 0.76329416 |
| 105 | MP0002722_abnormal_immune_system | 0.75922068 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.74975746 |
| 107 | MP0003329_amyloid_beta_deposits | 0.74918421 |
| 108 | MP0002928_abnormal_bile_duct | 0.74304585 |
| 109 | MP0001542_abnormal_bone_strength | 0.74128070 |
| 110 | MP0002166_altered_tumor_susceptibility | 0.73971712 |
| 111 | MP0005165_increased_susceptibility_to | 0.73528482 |
| 112 | MP0001851_eye_inflammation | 0.72023328 |
| 113 | MP0003448_altered_tumor_morphology | 0.71811958 |
| 114 | MP0003795_abnormal_bone_structure | 0.71624574 |
| 115 | MP0008873_increased_physiological_sensi | 0.70973420 |
| 116 | MP0005220_abnormal_exocrine_pancreas | 0.70608549 |
| 117 | MP0002877_abnormal_melanocyte_morpholog | 0.69256381 |
| 118 | MP0008874_decreased_physiological_sensi | 0.68895837 |
| 119 | MP0003866_abnormal_defecation | 0.68021696 |
| 120 | MP0002933_joint_inflammation | 0.67850727 |
| 121 | MP0003690_abnormal_glial_cell | 0.67165121 |
| 122 | MP0003091_abnormal_cell_migration | 0.66316516 |
| 123 | MP0009697_abnormal_copulation | 0.66284976 |
| 124 | MP0005023_abnormal_wound_healing | 0.61772619 |
| 125 | MP0002132_abnormal_respiratory_system | 0.60346152 |
| 126 | MP0005076_abnormal_cell_differentiation | 0.55057926 |
| 127 | MP0000703_abnormal_thymus_morphology | 0.54079057 |
| 128 | MP0000490_abnormal_crypts_of | 0.53164249 |
| 129 | MP0005535_abnormal_body_temperature | 0.52095825 |
| 130 | MP0005647_abnormal_sex_gland | 0.52012040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 6.19966367 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.19966367 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.08856150 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 4.92662298 |
| 5 | Optic neuritis (HP:0100653) | 4.92662298 |
| 6 | Stomatitis (HP:0010280) | 4.57886418 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 4.56925712 |
| 8 | Deep venous thrombosis (HP:0002625) | 4.43580291 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.35044600 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 4.26338968 |
| 11 | Complement deficiency (HP:0004431) | 4.20361002 |
| 12 | Xanthomatosis (HP:0000991) | 4.19213103 |
| 13 | Prolonged partial thromboplastin time (HP:0003645) | 4.06809437 |
| 14 | Joint hemorrhage (HP:0005261) | 3.95736689 |
| 15 | Vacuolated lymphocytes (HP:0001922) | 3.91131235 |
| 16 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.90514980 |
| 17 | Recurrent abscess formation (HP:0002722) | 3.85767068 |
| 18 | Disinhibition (HP:0000734) | 3.79790848 |
| 19 | Recurrent bacterial skin infections (HP:0005406) | 3.77656251 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 3.53300721 |
| 21 | Abnormality of complement system (HP:0005339) | 3.50755692 |
| 22 | Eczematoid dermatitis (HP:0000976) | 3.44534267 |
| 23 | Glomerulonephritis (HP:0000099) | 3.43907999 |
| 24 | Hyperlipoproteinemia (HP:0010980) | 3.43590336 |
| 25 | Keratoconjunctivitis sicca (HP:0001097) | 3.36490182 |
| 26 | Mutism (HP:0002300) | 3.24533064 |
| 27 | Hypobetalipoproteinemia (HP:0003563) | 3.22070215 |
| 28 | Abnormality of macrophages (HP:0004311) | 3.17086899 |
| 29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.11220707 |
| 30 | Keratoconjunctivitis (HP:0001096) | 3.06641316 |
| 31 | Chronic obstructive pulmonary disease (HP:0006510) | 3.03601444 |
| 32 | Obstructive lung disease (HP:0006536) | 3.03601444 |
| 33 | Pulmonary infiltrates (HP:0002113) | 2.94879150 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.93086743 |
| 35 | Myositis (HP:0100614) | 2.92355591 |
| 36 | Abnormality of the intrinsic pathway (HP:0010989) | 2.91727789 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.91581731 |
| 38 | Hypoglycemic coma (HP:0001325) | 2.90810532 |
| 39 | Hyperammonemia (HP:0001987) | 2.88637559 |
| 40 | Vasculitis (HP:0002633) | 2.87840091 |
| 41 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.82148122 |
| 42 | Increased IgM level (HP:0003496) | 2.81173090 |
| 43 | Nuclear cataract (HP:0100018) | 2.79407800 |
| 44 | Recurrent fungal infections (HP:0002841) | 2.77828847 |
| 45 | Dysostosis multiplex (HP:0000943) | 2.76124513 |
| 46 | Ketosis (HP:0001946) | 2.75418956 |
| 47 | Generalized aminoaciduria (HP:0002909) | 2.73756214 |
| 48 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.70605365 |
| 49 | Hemoptysis (HP:0002105) | 2.68531986 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.68123460 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.68123460 |
| 52 | Hypercholesterolemia (HP:0003124) | 2.65071082 |
| 53 | Gastrointestinal infarctions (HP:0005244) | 2.64595493 |
| 54 | Meningitis (HP:0001287) | 2.64310659 |
| 55 | Fat malabsorption (HP:0002630) | 2.63300167 |
| 56 | Myocardial infarction (HP:0001658) | 2.63032117 |
| 57 | Gangrene (HP:0100758) | 2.62860278 |
| 58 | Gingival bleeding (HP:0000225) | 2.61547897 |
| 59 | Neurofibrillary tangles (HP:0002185) | 2.60835207 |
| 60 | Increased cerebral lipofuscin (HP:0011813) | 2.60467897 |
| 61 | Recurrent skin infections (HP:0001581) | 2.59566975 |
| 62 | Axonal loss (HP:0003447) | 2.58299987 |
| 63 | Encephalitis (HP:0002383) | 2.57162116 |
| 64 | Hypolipoproteinemia (HP:0010981) | 2.53257387 |
| 65 | Autoimmune thrombocytopenia (HP:0001973) | 2.52855659 |
| 66 | Increased IgE level (HP:0003212) | 2.52197922 |
| 67 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.52158986 |
| 68 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.49729465 |
| 69 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.49729465 |
| 70 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.49729465 |
| 71 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.48267485 |
| 72 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.45136842 |
| 73 | Progressive neurologic deterioration (HP:0002344) | 2.43472856 |
| 74 | Orchitis (HP:0100796) | 2.42963408 |
| 75 | Amyloidosis (HP:0011034) | 2.42911371 |
| 76 | Hepatosplenomegaly (HP:0001433) | 2.42377850 |
| 77 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.42124501 |
| 78 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.41492590 |
| 79 | Abnormality of methionine metabolism (HP:0010901) | 2.41069027 |
| 80 | Hematochezia (HP:0002573) | 2.40221926 |
| 81 | Anorexia (HP:0002039) | 2.37342154 |
| 82 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.36722910 |
| 83 | T lymphocytopenia (HP:0005403) | 2.35527550 |
| 84 | Hypoalphalipoproteinemia (HP:0003233) | 2.34026735 |
| 85 | Arterial thrombosis (HP:0004420) | 2.33991369 |
| 86 | Epistaxis (HP:0000421) | 2.33467640 |
| 87 | Epidermoid cyst (HP:0200040) | 2.33226431 |
| 88 | Menorrhagia (HP:0000132) | 2.32549063 |
| 89 | Hyperbilirubinemia (HP:0002904) | 2.32184471 |
| 90 | Polyneuropathy (HP:0001271) | 2.31497432 |
| 91 | Episodic fever (HP:0001954) | 2.31406547 |
| 92 | Abnormality of nucleobase metabolism (HP:0010932) | 2.30789004 |
| 93 | Increased serum ferritin (HP:0003281) | 2.29480159 |
| 94 | Abnormality of iron homeostasis (HP:0011031) | 2.28848331 |
| 95 | Nephritis (HP:0000123) | 2.27895637 |
| 96 | Recurrent viral infections (HP:0004429) | 2.27879300 |
| 97 | Steatorrhea (HP:0002570) | 2.25659576 |
| 98 | Abnormality of purine metabolism (HP:0004352) | 2.25437211 |
| 99 | Neuronal loss in central nervous system (HP:0002529) | 2.22081328 |
| 100 | Esophageal varix (HP:0002040) | 2.21807409 |
| 101 | Apathy (HP:0000741) | 2.21730797 |
| 102 | Diminished motivation (HP:0000745) | 2.21711779 |
| 103 | Abnormality of T cell number (HP:0011839) | 2.20282652 |
| 104 | Pancreatitis (HP:0001733) | 2.18793867 |
| 105 | Nausea (HP:0002018) | 2.17131101 |
| 106 | Abnormal platelet function (HP:0011869) | 2.16167883 |
| 107 | Impaired platelet aggregation (HP:0003540) | 2.16167883 |
| 108 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.16057769 |
| 109 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.15451730 |
| 110 | Thrombophlebitis (HP:0004418) | 2.15055131 |
| 111 | Spontaneous hematomas (HP:0007420) | 2.14756496 |
| 112 | Hyperglycinuria (HP:0003108) | 2.14331844 |
| 113 | Late onset (HP:0003584) | 2.13750402 |
| 114 | Hypergammaglobulinemia (HP:0010702) | 2.13441434 |
| 115 | Upper motor neuron abnormality (HP:0002127) | 2.13283553 |
| 116 | Urticaria (HP:0001025) | 2.12588088 |
| 117 | Ketoacidosis (HP:0001993) | 2.10872231 |
| 118 | Dicarboxylic aciduria (HP:0003215) | 2.10870174 |
| 119 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.10870174 |
| 120 | Agnosia (HP:0010524) | 2.09847976 |
| 121 | Leukocytosis (HP:0001974) | 2.08631640 |
| 122 | Mediastinal lymphadenopathy (HP:0100721) | 2.07325550 |
| 123 | Conjugated hyperbilirubinemia (HP:0002908) | 2.04619846 |
| 124 | Abnormality of the pleura (HP:0002103) | 2.04222514 |
| 125 | Reduced antithrombin III activity (HP:0001976) | 2.02666985 |
| 126 | Loss of speech (HP:0002371) | 2.01095466 |
| 127 | Purpura (HP:0000979) | 2.00656386 |
| 128 | Interstitial pulmonary disease (HP:0006530) | 2.00366735 |
| 129 | Acne (HP:0001061) | 2.00322051 |
| 130 | Inappropriate behavior (HP:0000719) | 1.99636678 |
| 131 | Delayed CNS myelination (HP:0002188) | 1.99448590 |
| 132 | Periodontitis (HP:0000704) | 1.98421338 |
| 133 | Pustule (HP:0200039) | 1.96952908 |
| 134 | Abnormality of the pericardium (HP:0001697) | 1.96848551 |
| 135 | Prolonged neonatal jaundice (HP:0006579) | 1.96690069 |
| 136 | Pulmonary embolism (HP:0002204) | 1.94770850 |
| 137 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.94481939 |
| 138 | Abnormality of glycine metabolism (HP:0010895) | 1.94481939 |
| 139 | Thrombocytosis (HP:0001894) | 1.94221790 |
| 140 | Vertigo (HP:0002321) | 1.93641407 |
| 141 | Metabolic acidosis (HP:0001942) | 1.93593436 |
| 142 | Hyperglycinemia (HP:0002154) | 1.92446531 |
| 143 | Glomerulopathy (HP:0100820) | 1.91794127 |
| 144 | Gingivitis (HP:0000230) | 1.91726152 |
| 145 | Tetraparesis (HP:0002273) | 1.90621749 |
| 146 | Joint swelling (HP:0001386) | 1.90398818 |
| 147 | Malnutrition (HP:0004395) | 1.90074209 |
| 148 | Spontaneous abortion (HP:0005268) | 1.89554867 |
| 149 | Pathologic fracture (HP:0002756) | 1.89041950 |
| 150 | Recurrent cutaneous fungal infections (HP:0011370) | 1.88090066 |
| 151 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.88090066 |
| 152 | Petechiae (HP:0000967) | 1.87971444 |
| 153 | Arthralgia (HP:0002829) | 1.87803783 |
| 154 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.87445122 |
| 155 | Basal ganglia calcification (HP:0002135) | 1.87327304 |
| 156 | Thoracic kyphosis (HP:0002942) | 1.87274520 |
| 157 | Personality changes (HP:0000751) | 1.86874017 |
| 158 | Mitral stenosis (HP:0001718) | 1.86497765 |
| 159 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.86274008 |
| 160 | Chest pain (HP:0100749) | 1.86180576 |
| 161 | Cerebral inclusion bodies (HP:0100314) | 1.85670125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.23737061 |
| 2 | TBK1 | 3.28866310 |
| 3 | BCKDK | 3.07395310 |
| 4 | TAOK3 | 2.81774927 |
| 5 | TYK2 | 2.71965447 |
| 6 | KIT | 2.65191887 |
| 7 | IRAK3 | 2.53736457 |
| 8 | TAOK2 | 2.52609765 |
| 9 | MAP3K14 | 2.49122364 |
| 10 | BLK | 2.40324193 |
| 11 | TAOK1 | 2.24208739 |
| 12 | TGFBR2 | 2.22866160 |
| 13 | NME2 | 2.22685141 |
| 14 | IRAK4 | 2.16747787 |
| 15 | FLT3 | 2.13745568 |
| 16 | IKBKE | 2.10873758 |
| 17 | PRPF4B | 2.06164384 |
| 18 | MAP4K1 | 1.98181907 |
| 19 | DDR2 | 1.92834691 |
| 20 | FGR | 1.91132787 |
| 21 | IKBKB | 1.84853186 |
| 22 | FGFR4 | 1.83526922 |
| 23 | JAK3 | 1.76204709 |
| 24 | MAP2K3 | 1.72392580 |
| 25 | ABL2 | 1.63096216 |
| 26 | KDR | 1.61058941 |
| 27 | MAP3K13 | 1.60167719 |
| 28 | PIM2 | 1.51384522 |
| 29 | ZAP70 | 1.48641781 |
| 30 | TRIB3 | 1.47658296 |
| 31 | PKN2 | 1.43681020 |
| 32 | MOS | 1.42956394 |
| 33 | EPHB1 | 1.42374372 |
| 34 | BTK | 1.35749956 |
| 35 | TEC | 1.34192347 |
| 36 | NEK9 | 1.33898758 |
| 37 | CSF1R | 1.32138329 |
| 38 | TESK2 | 1.31783689 |
| 39 | MST1R | 1.31606433 |
| 40 | MAP3K6 | 1.29104872 |
| 41 | SIK3 | 1.28955431 |
| 42 | ERBB4 | 1.28076445 |
| 43 | TNK2 | 1.26334917 |
| 44 | CDC42BPA | 1.24368906 |
| 45 | MAP3K11 | 1.24082107 |
| 46 | PBK | 1.22899139 |
| 47 | JAK1 | 1.21614945 |
| 48 | JAK2 | 1.20152175 |
| 49 | RPS6KA4 | 1.14374985 |
| 50 | IRAK2 | 1.10392311 |
| 51 | ARAF | 1.09195044 |
| 52 | MUSK | 1.09100378 |
| 53 | RIPK4 | 1.07875989 |
| 54 | MAP3K3 | 1.06242066 |
| 55 | STK10 | 1.00887262 |
| 56 | MATK | 1.00764783 |
| 57 | CSK | 0.99934259 |
| 58 | PIK3CG | 0.99855293 |
| 59 | TGFBR1 | 0.99107273 |
| 60 | CHUK | 0.96485143 |
| 61 | SYK | 0.94394639 |
| 62 | MAP3K1 | 0.93982892 |
| 63 | ADRBK2 | 0.93174630 |
| 64 | ACVR1B | 0.90768596 |
| 65 | MAPK11 | 0.90637237 |
| 66 | MARK3 | 0.87260966 |
| 67 | TIE1 | 0.86868943 |
| 68 | KSR2 | 0.85596038 |
| 69 | TXK | 0.83852395 |
| 70 | LYN | 0.83521056 |
| 71 | MAP2K2 | 0.82211650 |
| 72 | PIM1 | 0.80642212 |
| 73 | SIK1 | 0.80536770 |
| 74 | NLK | 0.77968619 |
| 75 | LRRK2 | 0.72322673 |
| 76 | PTK6 | 0.70638513 |
| 77 | INSRR | 0.70455117 |
| 78 | TESK1 | 0.70369372 |
| 79 | HCK | 0.69613694 |
| 80 | MAPKAPK3 | 0.69419565 |
| 81 | EPHA3 | 0.68995121 |
| 82 | LCK | 0.67371792 |
| 83 | BMPR2 | 0.67005191 |
| 84 | GRK7 | 0.66783126 |
| 85 | MAP3K5 | 0.64411504 |
| 86 | MAP2K6 | 0.59508417 |
| 87 | EEF2K | 0.56877509 |
| 88 | MAP3K2 | 0.55763132 |
| 89 | STK16 | 0.55072173 |
| 90 | TYRO3 | 0.54935820 |
| 91 | PRKG2 | 0.54628051 |
| 92 | PDPK1 | 0.54555799 |
| 93 | PDK1 | 0.53065128 |
| 94 | MAPK4 | 0.51835395 |
| 95 | RAF1 | 0.49904456 |
| 96 | FES | 0.49059373 |
| 97 | SIK2 | 0.48806747 |
| 98 | ABL1 | 0.47929212 |
| 99 | SCYL2 | 0.47204009 |
| 100 | IRAK1 | 0.46817166 |
| 101 | CAMKK2 | 0.46268173 |
| 102 | PRKD2 | 0.46003493 |
| 103 | PRKCD | 0.45485615 |
| 104 | RPS6KC1 | 0.44312905 |
| 105 | RPS6KL1 | 0.44312905 |
| 106 | EIF2AK3 | 0.42569753 |
| 107 | DAPK2 | 0.41804045 |
| 108 | BMX | 0.40770289 |
| 109 | MARK2 | 0.40306470 |
| 110 | HIPK2 | 0.39333182 |
| 111 | RIPK1 | 0.37326095 |
| 112 | MAPKAPK2 | 0.37231254 |
| 113 | PINK1 | 0.37086210 |
| 114 | GRK6 | 0.36696376 |
| 115 | PRKAA2 | 0.36352327 |
| 116 | MAPK15 | 0.36337135 |
| 117 | CAMK1D | 0.35968959 |
| 118 | TRPM7 | 0.35828248 |
| 119 | RPS6KA6 | 0.35756562 |
| 120 | EGFR | 0.34131174 |
| 121 | DYRK1B | 0.34127375 |
| 122 | CDK6 | 0.34101269 |
| 123 | CLK1 | 0.33783983 |
| 124 | FYN | 0.32629663 |
| 125 | MAPK7 | 0.32590584 |
| 126 | STK4 | 0.32508352 |
| 127 | ITK | 0.31687810 |
| 128 | DYRK3 | 0.31504310 |
| 129 | MAP3K8 | 0.30308558 |
| 130 | RET | 0.29562882 |
| 131 | PAK4 | 0.29220297 |
| 132 | SMG1 | 0.26148841 |
| 133 | RPS6KA2 | 0.23067950 |
| 134 | MAPK12 | 0.19752388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.55568869 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.40836138 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.00001525 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.85101569 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.40239955 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.39195187 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.23671334 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.15381585 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.15112661 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.11074504 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.08874063 |
| 12 | Peroxisome_Homo sapiens_hsa04146 | 2.05113478 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.95302295 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.94894813 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.88732933 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.80638707 |
| 17 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.76035105 |
| 18 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.70594308 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.70487372 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.69823212 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.68560593 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.65996907 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.60425785 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.60293175 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.59892485 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.58083847 |
| 27 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.49288116 |
| 28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.49056338 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.48182795 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.46459109 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.40967143 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.40905932 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.40387623 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33242398 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.30856325 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.30646644 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.30337432 |
| 38 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.28634189 |
| 39 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.28477874 |
| 40 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.25764775 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.24870506 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.24563550 |
| 43 | Pertussis_Homo sapiens_hsa05133 | 1.24032266 |
| 44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.23361236 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.23114243 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.23021666 |
| 47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.20864457 |
| 48 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.19771649 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19735037 |
| 50 | Hepatitis C_Homo sapiens_hsa05160 | 1.18215192 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.16709760 |
| 52 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.16413357 |
| 53 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.16207674 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 1.15673096 |
| 55 | Retinol metabolism_Homo sapiens_hsa00830 | 1.14336574 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14238529 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.13259087 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 1.11975030 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.09974653 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.08952003 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 1.04633031 |
| 62 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.03559980 |
| 63 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.02362463 |
| 64 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.02135524 |
| 65 | Hepatitis B_Homo sapiens_hsa05161 | 1.01346978 |
| 66 | Malaria_Homo sapiens_hsa05144 | 1.00389535 |
| 67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98620826 |
| 68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.97358348 |
| 69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.96044848 |
| 70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.92215084 |
| 71 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.91489306 |
| 72 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.91252220 |
| 73 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.88842344 |
| 74 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.87986407 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.86705809 |
| 76 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.83520102 |
| 77 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.83161938 |
| 78 | Bladder cancer_Homo sapiens_hsa05219 | 0.81359955 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.80836722 |
| 80 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.79534894 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79384217 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78729768 |
| 83 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.78276805 |
| 84 | Carbon metabolism_Homo sapiens_hsa01200 | 0.77659768 |
| 85 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73388062 |
| 86 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.73355370 |
| 87 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.72985979 |
| 88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72913524 |
| 89 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.72842749 |
| 90 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.72643687 |
| 91 | Tuberculosis_Homo sapiens_hsa05152 | 0.72312093 |
| 92 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71188685 |
| 93 | Bile secretion_Homo sapiens_hsa04976 | 0.70149942 |
| 94 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.67956846 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67899583 |
| 96 | Protein export_Homo sapiens_hsa03060 | 0.67384885 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66534681 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66005166 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.64581921 |
| 100 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63578987 |
| 101 | Measles_Homo sapiens_hsa05162 | 0.61663189 |
| 102 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.60410222 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.59251556 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58494322 |
| 105 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.58466763 |
| 106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57384709 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57241115 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56848341 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.55873413 |
| 110 | Influenza A_Homo sapiens_hsa05164 | 0.55602963 |
| 111 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54803860 |
| 112 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53658584 |
| 113 | Phagosome_Homo sapiens_hsa04145 | 0.51257518 |
| 114 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51249997 |
| 115 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.50710200 |
| 116 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47427481 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47123620 |
| 118 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46812721 |
| 119 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.46201150 |
| 120 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45783523 |
| 121 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.45369489 |
| 122 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45195666 |
| 123 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.44972573 |
| 124 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.44795106 |
| 125 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.44447499 |
| 126 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.44337150 |
| 127 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.44143178 |
| 128 | Endocytosis_Homo sapiens_hsa04144 | 0.43943505 |
| 129 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43129702 |
| 130 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43026781 |
| 131 | Shigellosis_Homo sapiens_hsa05131 | 0.42361917 |
| 132 | Allograft rejection_Homo sapiens_hsa05330 | 0.42359555 |
| 133 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.41540807 |
| 134 | Apoptosis_Homo sapiens_hsa04210 | 0.41189520 |
| 135 | Asthma_Homo sapiens_hsa05310 | 0.41075486 |
| 136 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40667284 |
| 137 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.37838200 |
| 138 | Mineral absorption_Homo sapiens_hsa04978 | 0.36779618 |
| 139 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.36258710 |
| 140 | Platelet activation_Homo sapiens_hsa04611 | 0.35568444 |
| 141 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35508348 |
| 142 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33890814 |
| 143 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31251832 |
| 144 | Insulin resistance_Homo sapiens_hsa04931 | 0.31141115 |
| 145 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.28553730 |
| 146 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26154112 |
| 147 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25706362 |
| 148 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.23300570 |
| 149 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21786437 |
| 150 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21642320 |
| 151 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.18309480 |
| 152 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.15884774 |
| 153 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.14654632 |
| 154 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.12648478 |
| 155 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.12483520 |
| 156 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.09300664 |

